By Hayley Virgil, CancerNetwork
Artificial intelligence (AI) may better aid in diagnosing patients with prostate cancer, detecting recurrence, and even guiding treatment with radiotherapy, according to Wayne G. Brisbane, MD.
In a recent conversation between CancerNetwork® and Brisbane, an assistant professor of urology at the University of California, Los Angeles (UCLA) Health, highlighted the use of AI in testing for prostate cancer as well as a few studies that have been conducted on its use in the space.
Results from a retrospective study published in European Urology Open Science, which examined whether AI could be used to predict and map intraprostatic tumor extent, indicated that the model was accurate and efficacious in an independent test set.1 Investigators were able to conclude that the strategy could possibly improve treatment margin definition, thereby decreasing recurrence.
